Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Donald A Bergstrom Insider Profile
4 Followers
Donald A Bergstrom, Chief Medical Officer at Mersana Therapeutics, holds ― shares in Mersana Therapeutics (Ticker: MRSN), holds 527.43K shares in Relay Therapeutics (Ticker: RLAY), holds ― shares in Fusion Pharmaceuticals (Ticker: FUSN). Most recently, Donald A Bergstrom ― shares of Mersana Therapeutics on ― for an estimated value of ―.
Donald A Bergstrom Mersana Therapeutics (MRSN)Chief Medical Officer
Mersana Therapeutics (MRSN)
Chief Medical Officer
Ranked #484 out of 98,624 Corporate Insiders
Profitable Transactions
20 out of 20 Profitable Transactions
Average Return
+41.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Donald A Bergstrom holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Nov 01, 2022 - Nov 01, 2023
Return:+69.50%
The most profitable trade made by Donald A Bergstrom
Donald A Bergstrom's Trading History
Mersana Therapeutics
―
Chief Medical Officer
―
―
Relay Therapeutics
Apr 29, 2024
President, R&D
Informative Sell
17.14K
$3.51M
Fusion Pharmaceuticals
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Donald A Bergstrom's performance on stock
You May Also Like
Donald A Bergstrom insider profile FAQ
What is the percentage of profitable transactions made by Donald A Bergstrom?
The percentage of profitable transactions made by Donald A Bergstrom is 100%.
What is the average return per transaction made by Donald A Bergstrom?
The average return per transaction made by Donald A Bergstrom is 41.60%.
What stocks does Donald A Bergstrom hold?
Donald A Bergstrom holds: MRSN, RLAY, FUSN stocks.
What was Donald A Bergstrom’s latest transaction?
Donald A Bergstrom latest transaction was an Uninformative Buy of ―.
What was Donald A Bergstrom's most profitable transaction?
Donald A Bergstrom’s most profitable transaction was an Informative Sell of RLAY stock on November 1, 2022. The return on the trade was 69.50%.
What is Donald A Bergstrom's role in Mersana Therapeutics?
Donald A Bergstrom's role in Mersana Therapeutics is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.